CG
MNTA

Cutler Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cutler Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-500
Closed -$1K – 6366
2017
Q3 		$1K Sell
500
-1,900
-79% -$31.8K ﹤0.01% 5667
2017
Q2 		$1K Buy
+2,400
New +$36.5K ﹤0.01% 6148
2017
Q1 		– Sell
-1,400
Closed -$2K – 7574
2016
Q4 		$2K Buy
+1,400
New +$18.5K ﹤0.01% 5790

Cutler Group's MNTA Position: Q4 2020 in Review

Cutler Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 200 shares — an estimated $10K sold.

Cutler Group first reported a position in MNTA in Q2 2016 and held it in 6 quarters. The position peaked at $311K in Q4 2016. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Cutler Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 200 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $10K.
  • Cutler Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 6 quarters.
  • Cutler Group's Momenta Pharmaceuticals, Inc. position peaked at $311K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.